• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
143.96
432096.23
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.89
 

hcl technologies ltd
Sammaan Capital receives upgrade in credit ratings of LT debt programme
May 13,2026
Sammaan Capital announced that CARE Ratings has upgraded the credit rating assigned to the long-term debt programme of Sammaan Capital by two notches to ‘CARE AA+; Stable'.

Further, the rating assigned to the Commercial Paper and Short-Term Non-Convertible Debentures of the Company has been reaffirmed at ‘CARE A1+'. Also CARE Ratings has upgraded the rating assigned to the Company's perpetual debt instruments to ‘CARE AA/Stable' from ‘CARE A+'.